Financial Year |
September 30 2020 |
Monetary Funds |
267,841,416.53 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
310,000.00 |
Accounts Receivable |
294,689,777.25 |
Advances to Suppliers |
747,019,498.19 |
Other Receivables |
1,293,913,754.16 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
5,500,371.98 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
128,189,972.13 |
Total Current Assets |
2,737,464,790.24 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
36,393,639.22 |
Investment Properties |
-- |
Fixed Assetes |
234,189,568.67 |
Under-construction Projects |
1,333,567,468.89 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
4,967,433,367.25 |
Intangible Assets |
289,296,787.44 |
R&D expenses |
-- |
Goodwill |
326,604,869.38 |
Long-Term Deferred and Prepaid Expenses |
19,927,520.48 |
Deferred Income Tax Assets |
-- |
Other Non-Current Assets |
243,297,812.38 |
Sub-Total of Non-Current Assets |
7,639,687,625.06 |
Total Assets |
10,377,152,415.30 |
Short-Term Loans |
3,006,366,675.23 |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
361,948,960.46 |
Accounts Received In Advance |
11,493,031.24 |
Employee Compensation Payable |
2,834,110.92 |
Taxes Payable |
45,108,739.49 |
Interest Payable |
274,263,322.87 |
Dividend Payable |
-- |
Other payables |
2,136,168,070.80 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
298,494,914.43 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
5,862,414,502.57 |
Long-term Loans |
1,941,023,363.98 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
2,284,588,030.48 |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
4,225,611,394.46 |
Total Liabilities |
10,088,025,897.03 |
Paid-In Capital(Or Share Stock) |
587,674,264.00 |
Capital Surplus |
2,808,011,922.29 |
Surplus Reserve |
47,934,026.44 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-3,053,706,943.23 |
Minority Stockholder's Interest |
123,121,156.55 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
166,005,361.72 |
Owner's Equity(Stockholder's Equity) |
289,126,518.27 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
10,377,152,415.30 |